Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
An oral abstract presentation by Dr. David Fleischer, FAAAAI, FACAAI, Professor of Pediatrics at Children’s Hospital Colorado, will describe Month 60 (M60), end-of-study efficacy and safety results ...
After hours: 7:57:23 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback